Suchergebnisse - "Curigliano, G"

PubPharm (6)

1

Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer : An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511

enthalten in: Cancer treatment reviews | 2023

von Miglietta, F. | Fabi, A. | Generali, D. | +14

ErratumFor: Cancer Treat Rev. 2023 Mar;114:102511. - PMID 36638600

2

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer : An Italian consensus paper and critical review

enthalten in: Cancer treatment reviews | 2023

von Miglietta, F. | Fabi, A. | Generali, D. | +14

ErratumIn: Cancer Treat Rev. 2023 Jun;117:102570. - PMID 37150120

3

Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer : An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511

enthalten in: Cancer treatment reviews | 2023

von Miglietta, F. | Fabi, A. | Generali, D. | +14

ErratumFor: Cancer Treat Rev. 2023 Mar;114:102511. - PMID 36638600

4

Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis

enthalten in: Cancer treatment reviews | 2021

von Trillo Aliaga, P. | Spada, F. | Peveri, G. | +9

5

Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis

enthalten in: Cancer treatment reviews | 2021

von Trapani, D. | Gandini, S. | Corti, C. | +6

6

The global landscape of drug development for kidney cancer

enthalten in: Cancer treatment reviews | 2020

von Trapani, D. | Curigliano, G. | Alexandru, E. | +1

1
[1]